Characterization of six bioactive compounds from two soil-derived Streptomyces strains, F9 and F4 from Iran

Sara Ghashghaei, Helge B. Bode, Zahra Etemadifar, Yan-Ni Shi, Peter Grün, Mohammad Reza Mofid

Abstract


Background and purpose: Actinobacteria are highly valuable in the pharmaceutical industry due to their unlimited capacity to produce natural products. In line with the screening of actinomycetes to discover new antibacterial agents, this study isolated and elucidated bioactive compounds from two Streptomyces strains, F9 (99.88% similarity with S. chryseus) and F4 (99.14% similarity with S. rectiviolaceus).

Experimental approach: The present study followed a rigorous experimental approach. Previously, two Streptomyces strains, F9 and F4, were isolated and identified. These strains were then selected for the isolation and elucidation of secondary metabolites. The crude extract was semi-purified using Waters, and the active fractions were further purified using Agilent. The structure of the isolated compounds was elucidated through detailed spectroscopic analysis to ensure the accuracy and reliability of the findings.

Findings/Results: Four fractions isolated from strain F9 showed antibacterial activity against test microorganisms. HR-ESI-MS, fragmentation pattern, and database search identified chrysomycins B and C. The structure of chrysomycins A and 4'-O-acetylated A was confirmed by 1D and 2D-NMR data. In addition, the findings characterized 2 pigments produced by strain F4 using HR-ESI-MS and fragmentation pattern (ESI-MS/MS), which revealed that major and minor peaks corresponded to butyl-meta-cycloheptylprodiginine and undecylprodiginine, respectively.

Conclusion and implications: Six bioactive compounds, including 4 chrysomycins and 2 pigments, were isolated from 2 Streptomyces strains, F9 and F4. Importantly, this was the first report on isolating chrysomycins A-C and 4'-O-acetylated A from S. chryseus.

 


Keywords


Anti-bacterial agents; Butyl-meta-cycloheptylprodiginine; Chrysomycin; Streptomyces; Undecylprodiginine.

Full Text:

PDF

References


Fazeli H, Salehi R. Antibiotic resistance pattern in Shiga toxin-producing Escherichia coli isolated from diarrheal patients in Al-zahra hospital, Isfahan, Iran. Res Pharm Sci. 2007;2:29-33.

Jain SK, Pathania AS, Parshad R, Raina C, Ali A, Gupta AP, et al. Chrysomycins A-C, antileukemic naphthocoumarins from Streptomyces sporoverrucosus. RSC Adv. 2013;3(43):21046-21053.DOI: 10.1039/C3RA42884B.

Lee LH, Zainal N, Azman AS, Eng SK, Goh BH, Yin WF, et al. Diversity and antimicrobial activities of actinobacteria isolated from tropical mangrove sediments in Malaysia. Scientific World J. 2014;2014:698178,1-14.DOI: 10.1155/2014/698178.

Hou J, Liu P, Qu H, Fu P, Wang Y, Wang Z, et al. Gilvocarcin HE: a new polyketide glycoside from Streptomyces sp. J Antibiot. 2012;65(10):523-526.DOI: 10.1038/ja.2012.61.

Wada SI, Sawa R, Iwanami F, Nagayoshi M, Kubota Y, Iijima K, et al. Structures and biological activities of novel 4’-acetylated analogs of chrysomycins A and B. J Antibiot. 2017;70(11):1078-1082.DOI: 10.1038/ja.2017.99.

Strelitz F, Flon H, Asheshov IN. Chrysomycin: A new antibiotic substance for bacterial viruses. J Bacteriol. 1955;69(3):280-283.

Weiss U, Yoshihira K, Highet RJ, White RJ, Wei TT. The chemistry of the antibiotics chrysomycin A and B. Antitumor activity of chrysomycin A. J Antibiot. 1982;35(9):1194-1201.DOI: 10.7164/antibiotics.35.1194.

Wu F, Zhang J, Song F, Wang S, Guo H, Wei Q, et al. Chrysomycin A derivatives for the treatment of multi-drug-resistant tuberculosis. ACS Cent Sci. 2020;6(6):928-938.DOI: 10.1021/acscentsci.0c00122.

Muralikrishnan B, Edison LK, Dusthackeer A, Jijimole GR, Ramachandran R, Madhavan A, et al. Chrysomycin A inhibits the topoisomerase I of Mycobacterium tuberculosis. J Antibiot. 2022;75(4):226-235.DOI: 10.1038/s41429-022-00503-z.

Hassan M, Ghaffari R, Sardari S, Farmahini Farahani Y, Mohebbi S. Discovery of novel isatin-based thiosemicarbazones: synthesis, antibacterial, antifungal, and antimycobacterial screening. Res Pharm Sci. 2020;15(3):281-290.DOI: 10.4103/1735-5362.288435.

Liu R, Cui CB, Duan L, Gu QQ, Zhu WM. Potent in vitro anticancer activity of metacycloprodigiosin and undecylprodigiosin from a sponge-derived actinomycete Saccharopolyspora sp. nov. Arch Pharm Res. 2005;28(12):1341-1344. DOI: 10.1007/BF02977899.

Sydor PK. Elucidation of the prodiginine biosynthetic pathway in Streptomyces coelicolor A3 (2). Ph.D. [Thesis]. Coventry, United Kingdom: University of Warwick; 2010.

Niakani M, Majd A, Pakzad P, Malekinejad H. Prodigiosin induced the caspase-dependent apoptosis in human chronic myelogenous leukemia K562 cell. Res Pharm Sci. 2021;16(1):26-34.DOI: 10.4103/1735-5362.305186.

Montgomery LJ. Investigations of the biosynthesis and biomimetic synthesis of bioactive natural products. Ph.D. [Thesis]. Coventry, United Kingdom: University of Warwick; 2008.

Southon IW, Buckingham J. Dictionary of alkaloids. 2nd edition. London and New York: Chapman and Hall/CRC;1989.

Chen K. Applications of mass spectrometry to analysis of prodiginines, bioactivated methylenedianiline intermediates, and hypoxia induced changes in the zebrafish skeletal muscle proteome. Ph.D. [Thesis]. Louisiana, United States: University of New Orleans; 2008.

Alihosseini F, Lango J, Ju KS, Hammock BD, Sun G. Mutation of bacterium Vibrio gazogenes for selective preparation of colorants. Biotechnol Prog. 2010;26(2):352-360.DOI: 10.1002/btpr.346.

Ghashghaei S, Etemadifar Z, Shi YN, Grün P, Mofid MR, Bode HB. Optimization of degenerate PCR conditions for reducing error rates in detection of PKS and NRPS gene groups in Actinomycetes. Avicenna J Med Biotechnol. 2023;15(1):28-37.DOI: 10.18502/ajmb.v15i1.11422.

Ghashghaei S, Etemadifar Z, Mofid MR. Studies on the kinetics of antibacterial agent production in two actinomycete strains, F9 and Is5, isolated from soil samples, Iran. Iran J Sci Technol Trans A Sci. 2018;42(3):1139-1147.DOI: 10.1007/s40995-017-0171-7.

Rula Darwish R, Almaaytah A, Salama A. The design and evaluation of the antimicrobial activity of a novel conjugated penta-ultrashort antimicrobial peptide in combination with conventional antibiotics against sensitive and resistant strains of S. aureus and E. coli. Res Pharm Sci. 2022;17(6):612-620.DOI: 10.4103/1735-5362.359429.

Hu Z, Weng Q, Cai Z, Zhang H. Optimization of fermentation conditions and medium components for chrysomycin A production by Streptomyces sp. 891-B6. BMC Microbiol. 2024;24(1):120,1-8.DOI: 10.1186/s12866-024-03258-9.

Gupta P, Samant K, Sahu A. Isolation of cellulose-degrading bacteria and determination of their cellulolytic potential. Int J Microbiol. 2012;2012:1-5.DOI: 10.1155/2012/578925.

Poosarla A, Ramana LV, Krishna RM. Isolation of potent antibiotic producing actinomycetes from marine sediments of andaman and nicobar marine islands. J Microbiol Antimicrob. 2013;5(1):6-12.DOI: 10.5897/jma11.075.

Hegemann JD, Van Der Donk WA. Investigation of substrate recognition and biosynthesis in class IV lanthipeptide systems. J Am Chem Soc. 2018;140(17):5743-5754.DOI: 10.1021/jacs.8b01323.

Ni HJ, Lv SY, Sheng YT, Wang H, Chu XH, Zhang HW. Optimization of fermentation conditions and medium compositions for the production of chrysomycin A by a marine-derived strain Streptomyces sp. 891. Prep Biochem Biotechnol. 2021;51(10):998-1003.DOI: 10.1080/10826068.2021.1885046.

Chen K, Rannulu NS, Cai Y, Lane P, Liebl AL, Rees BB, et al. Unusual odd-electron fragments from even-electron protonated prodiginine precursors using positive-ion electrospray tandem mass spectrometry. J Am Soc Mass Spectrom. 2008;9(12):1856-1866.DOI: 10.1016/j.jasms.2008.08.002.


Refbacks

  • There are currently no refbacks.


Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.